Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus.

@article{Garg2011EffectOT,
  title={Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus.},
  author={Varun Garg and R. P. G. van Heeswijk and Jee Eun Lee and K{\'a}tia Cristiane Alves and Priya P Nadkarni and Xia Luo},
  journal={Hepatology},
  year={2011},
  volume={54 1},
  pages={20-7}
}
UNLABELLED The hepatitis C virus protease inhibitor telaprevir is an inhibitor of the enzyme cytochrome P450 3A, responsible for the metabolism of both cyclosporine and tacrolimus. This Phase I, open-label, nonrandomized, single-sequence study assessed the effect of telaprevir coadministration on the pharmacokinetics of a single dose of either cyclosporine or tacrolimus in two separate panels of 10 healthy volunteers each. In Part A, cyclosporine was administered alone as a single 100-mg oral… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 119 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 29 references

Telaprevir-based therapy in G1 HCV-infected patients with prior null response, partial response or relapse to peginterferon/ribavirin: REALIZE trial final results [Abstract

  • G Foster, S Zeuzem, P Andreone, S Pol, E Lawitz, M Diago
  • Hepatol Int 2011;5:14
  • 2011

The effect of low-dose ritonavir on the pharmacokinetics of the investigational HCV protease inhibitor telaprevir in healthy volunteers

  • V Garg, X Luo, R van Heeswijk, RS. Kauffman
  • Poster: Conference on Retroviruses and…
  • 2011

Telaprevir in combination with peginterferon and ribavirin in genotype 1 HCV treatment-naı̈ve patients: final results of Phase 3 ADVANCE study [Abstract

  • IM Jacobson, JG McHutchison, GM Dusheiko, MA DiBisceglie, R Reddy, NH Bzowej
  • HEPATOLOGY
  • 2010

The pharmacokinetic (PK) interaction between tenofovir disoproxil fumarate (TDF) and the investigational HCV protease inhibitor telaprevir (TVR) [Abstract

  • R Van Heeswijk, V Gysen, G Boogaerts, E de Paepe, T Vangeneugen, K de Backer
  • 48th International Conference on Antimicrobial…
  • 2008
1 Excerpt

Similar Papers

Loading similar papers…